MicroRNAs (miRNAs) are∼ 22 nt RNAs that direct posttranscriptional repression of mRNA
targets in diverse eukaryotic lineages. In humans and other mammals, these small RNAs …

Micro RNA s (mi RNA s) have within the past decade emerged as key regulators of
metabolic homoeostasis. Major tissues in intermediary metabolism important during …

The prevalence of overweight and obesity in developed and develo** countries has
greatly increased the risk of insulin resistance and type 2 diabetes mellitus. It is evident from …

Stimulating regeneration of complex tissues and organs after injury to effect complete
structural and functional repair, is an attractive therapeutic option that would revolutionize …

The treatment of diabetes mellitus represents one of the greatest medical challenges of our
era. Diabetes results from a deficiency or functional impairment of insulin-producing β cells …

Background MicroRNAs have emerged as important regulatory non-coding RNAs that tune
cellular responses to physiological perturbations and disease conditions. An increasing …

Diabetes mellitus (DM), a complex metabolic disease, has become a global threat to human
health worldwide. Over the past decades, an enormous amount of effort has been devoted to …

Aims MicroRNAs are a class of negative regulators of gene expression, which have been
shown to be involved in the development of endocrine pancreas and in the regulation of …

Introduction: Diabetes mellitus is a very common metabolic disorder affecting more than 400
million people worldwide. Currently available treatments permit to manage the disease but …

Noncoding RNA and especially microRNAs (miRs) have emerged as important regulators of
key processes in cell biology, including development, differentiation, and survival. Currently …